News for Abbott Laboratories (ABT.SN)

Abbott Laboratories partners with Tandem Diabetes for advanced diabetes management solutions. Wall Street analysts see significant upside potential for

Ryan Finley explains why the Tax Court’s confirmation of the cost-sharing regulations’ validity was more important than its findings of fact in the case of Facebook.

PR NewswireNEW YORK, June 7, 2025 NEW YORK, June 7, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Reckitt

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Reckitt Benckiser Group Plc (”œReckitt

In our monthly Rare Stock Picks series, we're highlighting May 2025 investment picks. Click here for the list of May 2025 Buy recommendations.

Market Analysis by covering: S&P 500, Allergan PLC, Sherwin-Williams Co, PPG Industries Inc. Read 's Market Analysis on Investing.com

How global companies have fared since the US president’s inauguration

Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

(Bloomberg) -- The US Federal Trade Commission is investigating whether more than a dozen media and advertising groups have illegally colluded to boycott online content alleged to be hateful, false or misleading, according to people familiar with the matter and a document seen by Bloomberg News.Most Read from BloombergWhere the Wild Children’s Museums AreBillionaire Steve Cohen Wants NY to Expand Taxpayer-Backed FerryThe Economic Benefits of Paying Workers to MoveAt London’s New Design Museum, V

Market Analysis by covering: Medtronic PLC, Abbott Laboratories, Lyondellbasell Industries NV, Flowers Foods Inc. Read 's Market Analysis on Investing.com

Analyzing the Strategic Moves in the First Quarter of 2025 MS Global Franchise Portfolio (Trades, Portfolio) recently submitted its N-PORT filing for the first

Coca-Cola, Abbott, and AT&T beat peers YTD with strong earnings, innovation, and strategic moves, but face headwinds from FX, costs, and competition.

Stock prices have recovered, but the business impact has yet to kick in.

Polen Capital, an investment management company, released its “Polen Global Growth Strategy” first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Global equity markets experienced a surge in volatility in 2025 due to US tariffs, with the “Magnificent 7” falling 15% and semiconductors dropping 19%. U.S. stocks lagged, with international equities […]

We recently published a list of Jim Cramer Nailed These 11 Stock Predictions. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that Jim Cramer discusses. Back in 2024, on May 20, a caller asked whether to hold or buy more shares of Abbott Laboratories […]

Zoetis is a leading animal health company with a deep lineup and significant long-term tailwinds. Abbott Labs has a diversified portfolio of medical devices and several attractive growth avenues. The fact that the stock market will sometimes go through erratic periods is not a good reason not to invest.

Investment ThesisWith 7% top-line growth and 8% bottom-line growth across the majority of its divisions, Abbott Labs reported a solid first-quarter performance.

Nuclear verdicts against corporate defendants reached a record high in 2024, led by cases involving products liability and intellectual property,

Total capital raise of $77.8 million strengthens company's financial position. Strategic investment from Abbott Laboratories, a major healthcare company